A dynamic inflammatory cytokine network in the human ovarian cancer microenvironment

Cancer Research

Volumn 72, Issue 1, 2012, Pages 66-75

  Kulbe, Hagen ^a   Chakravarty, Probir ^b   Leinster, D Andrew ^a   Charles, Kellie A ^a   Kwong, Joseph ^a   Thompson, Richard G ^a   Coward, Jermaine I ^a   Schioppa, Tiziana ^a   Robinson, Stephen C ^a   Gallagher, William M ^c   Galletta, Laura ^e   Salako, Michael A ^a   Smyth, John F ^d   Hagemann, Thorsten ^a   Brennan, Donal J ^c   Bowtell, David D ^e   Balkwill, Frances R ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

^d WESTERN GENERAL HOSPITAL   (United Kingdom)

^e UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; INFLIXIMAB; INTERLEUKIN 6; NOTCH RECEPTOR; STROMAL CELL DERIVED FACTOR 1; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOCRINE EFFECT; BONE MARROW CELL; CELL INFILTRATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATION; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARY CANCER; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR BIOPSY; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; TUMOR XENOGRAFT;

ANIMALS; BIOPSY; CELL LINE, TUMOR; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, NUDE; OVARIAN NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84855393623     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-11-2178     Document Type: Article

References (23)

1. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008;454:436-44.
2. Szlosarek PW, Grimshaw MJ, Kulbe H, Wilson JL, Wilbanks GD, Burke F, et al. Expression and regulation of tumor necrosis factor-alpha in normal and malignant ovarian epithelium. Mol Cancer Therapy 2006;5:382-90.
3. Kulbe H, Thompson RT, Wilson J, Robinson SC, Hagemann T, Fatah R, et al. The inflammatory cytokine TNF-alpha generates an autocrine tumour-promoting network in epithelial ovarian cancer cells. Cancer Res 2007;67:585-92. (Pubitemid 46192196)
4. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002;296:550-3. (Pubitemid 34408678)
5. Team RDC. R: A language and environment for statistical computing. R Foundation for Statistical computing 2008; ISBN 3-900051-07-0: Avalilable from: http://www.R-project.org
6. Smyth GK. Limma: linear models for microarray data. Bioinformatics and Computational Biology Solutions using R and Bioconductor 2005:397-420.
7. Gautier L, Cope L, Bolstad BM, Irizarry RA. Affy-analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 2004;20:307-15. Available from: http://bioconductor.org (Pubitemid 38262761)
8. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc, Ser B 1995;57:289-300.
9. Network TCGAR. Integrated genomic analyses of ovarian carcinoma. Nature 2011;474:609-15. Avaliable from: http://tcga-data.nci.nih.gov/tcga/
10. Abbas AR, Baldwin D, Ma Y, Ouyang W, Gurney A, Martin F, et al. Immune response in silico (IRIS): immune-specific genes identified from a compendium of microarray expression data. Genes Immun 2005;6:319-31. (Pubitemid 40903405)
11. Charles KA, Kulbe H, Soper R, Escorcio-Correia M, Lawrence T, Schultheis A, et al. The tumor-promoting actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in mice and humans. J Clin Invest 2009;119:3011-23.
12. Brennan DJ, Brandstedt J, Rexhepaj E, Foley M, Ponten F, Uhlen M, et al. Tumour-specific HMG-CoAR is an independent predictor of recurrence free survival in epithelial ovarian cancer. BMC Cancer 2010;10:125.
13. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005;43:15545-50. (Pubitemid 41528093)
14. Park JT, Li M, Nakayama K, Mao TL, Davidson B, Zhang Z, et al. Notch3 gene amplification in ovarian cancer. Cancer Res 2006;15:6312-8.
15. Choi J-H, Park JT, Davidson B, Morin PJ, Shih I-M, Wang T-L. Jagged-1 and Notch3 juxtacrine loop regulates ovarian tumor growth and adhesion. Cancer Res 2008;68:5716-23.
16. Madhusudan S, Muthuramalingam SR, Braybrooke JP, Wilner S, Kaur K, Han C, et al. A phase II study of ethanercept (ENBREL) a tumour necrosis factor-alpha inhibitor in recurrent ovarian cancer. J Clin Oncol 2005;23:5950-9.
17. Coward J, Kulbe H, Chakravarty P, Leader D, Vassileva V, Leinster DA, et al. Interleukin-6 as a therapeutic target in human ovarian cancer. Clin Cancer Res 2011;17:6083-96.
18. Vaughan S, Coward J, Bast RC Jr, Berchuck A, Berek JS, Brenton JD, et al. Rethinking ovarian cancer: recommendations for improving outcomes. Nat Rev Cancer 2011;11:719-25.
19. Anglesio MS, George J, Kulbe H, Friedlander M, Rischin D, Lemech C, et al. IL6-STAT3-HIF signaling and therapeutic response to the angiogenesis inhibitor sunitinib in ovarian clear cell cancer. Clin Cancer Res 2011;17:2538-48.
20. Bowtell DD. The genesis and evolution of high-grade serous ovarian cancer. Nat Rev Cancer 2010;10:803-8.
21. Wiegand KC, Shah SP, Al-Agha OM, Zhao Y, Tse K, Zeng T, et al. ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med 2010;363:1532-43.
22. Citri A, Yarden Y. EGF-ERBB signalling: towards the systems level. Nat Rev Mol Cell Biol 2006;7:505-16. (Pubitemid 44036456)
23. Bubil EM, Yarden Y. The EGF receptor family: spearheading a merger of signaling and therapeutics. Curr Opin in Cell Biol 2007;19:124-34. (Pubitemid 46386405)